08/08/2025
7:55 AM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form DEF 14A | |
08/06/2025
11:19 AM | FMR LLC (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form SCHEDULE 13G/A | |
08/04/2025
5:08 PM | Lundberg Sven Ante (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2025
4:01 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2025
4:11 PM | Cumbo Alexander (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2025
4:12 PM | Detheux Michel (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2025
4:14 PM | Cumbo Alexander (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2025
4:16 PM | Detheux Michel (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
3:07 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2025
4:29 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2025
3:22 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for VOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vor Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
07/09/2025
4:00 PM | 5AM Ventures VI, L.P. (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form SCHEDULE 13D/A | |
07/02/2025
3:40 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2025
4:15 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2025
8:18 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2025
4:45 PM | Namouni Fouad (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Patterson Matthew R (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Beckman Daniella (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Lubner David Charles (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Lundberg Sven Ante (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Kalir Erez (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Resnick Joshua (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:47 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:05 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:35 AM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
3:30 PM | Choi Han Wook (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
11:15 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form EFFECT | |
03/28/2025
3:33 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form PRE 14A | |
03/20/2025
3:45 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/20/2025
3:48 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2025
3:01 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2025
3:29 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:34 AM | FMR LLC (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
3:35 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:36 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:37 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:01 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
8:19 PM | Choi Han Wook (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:20 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:22 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:23 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Altucher: Trump’s Great Gain is starting (Ad) New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun.
Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation. See Altucher’s Trump crypto prediction here |
01/29/2025
11:15 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form EFFECT | |
01/29/2025
4:24 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 424B3 | |
01/21/2025
3:24 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/08/2025
5:39 PM | Kalir Erez (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
5:41 PM | Kalir Erez (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
8:06 AM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:53 PM | Reprogrammed Interchange LLC (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form SCHEDULE 13D | |
01/02/2025
6:37 PM | Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
6:42 PM | Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
5:51 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form SCHEDULE 13D/A | |
12/30/2024
5:52 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:17 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
8:05 AM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
6:39 AM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:33 PM | Paradigm Biocapital Advisors LP (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form SC 13G/A | |
11/08/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:20 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
3:16 PM | Choi Han Wook (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
3:17 PM | Choi Han Wook (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
6:05 AM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:06 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:01 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
